(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-03 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 845290
Date | Daily Closing Price | Open | High | Low | Volume |
03 Tue Sep 2024 | 45.52 | 47.37 | 48.27 | 45.19 | 1.325 times |
30 Fri Aug 2024 | 47.72 | 47.72 | 48.18 | 47.00 | 0.918 times |
30 Fri Aug 2024 | 47.72 | 47.72 | 48.18 | 47.00 | 0.918 times |
29 Thu Aug 2024 | 47.55 | 47.80 | 48.71 | 47.45 | 0.801 times |
28 Wed Aug 2024 | 47.48 | 48.00 | 48.44 | 46.86 | 0.836 times |
27 Tue Aug 2024 | 48.24 | 48.60 | 48.79 | 47.57 | 0.913 times |
26 Mon Aug 2024 | 49.17 | 49.15 | 49.62 | 48.31 | 0.835 times |
23 Fri Aug 2024 | 48.69 | 47.99 | 49.24 | 47.17 | 1.007 times |
22 Thu Aug 2024 | 47.50 | 50.05 | 50.10 | 47.34 | 1.323 times |
21 Wed Aug 2024 | 49.99 | 49.38 | 50.22 | 49.00 | 1.314 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 45.6, for a target of 46.9 or 47.94
Share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Target | 44.80 |
Upside Target | 46.86 |
Upside Target | 48.18 |
Upside Target | 50.73 |
Upside Target | 51.02 |
Upside Target | 52.31 |
Upside Target | 53.33 |
Upside Target | 57.68 |
Upside Target | 59.18 |
Upside Target | 63.68 |
Upside Target | 67.88 |
Intraday share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Intraday Target | 44.38 |
Downside Intraday Target | 43.25 |
Upside Intraday Target | 47.46 |
Upside Intraday Target | 49.41 |
Upside Intraday Target | 46.33 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
Date | Weekly Closing Price | Open | High | Low | Volume |
03 Tue Sep 2024 | 45.52 | 47.37 | 48.27 | 45.19 | 1.443 times |
30 Fri Aug 2024 | 47.72 | 47.72 | 48.18 | 47.00 | 0.213 times |
30 Fri Aug 2024 | 47.72 | 49.15 | 49.62 | 46.86 | 0.729 times |
23 Fri Aug 2024 | 48.69 | 47.85 | 50.73 | 47.17 | 0.809 times |
16 Fri Aug 2024 | 47.85 | 47.04 | 48.94 | 45.61 | 0.777 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
Date | Monthly Closing Price | Open | High | Low | Volume |
03 Tue Sep 2024 | 45.52 | 47.37 | 48.27 | 45.19 | 0.041 times |
30 Fri Aug 2024 | 47.72 | 57.39 | 57.68 | 44.80 | 0.967 times |
31 Wed Jul 2024 | 57.29 | 54.02 | 63.68 | 52.31 | 0.995 times |
28 Fri Jun 2024 | 54.01 | 54.82 | 67.88 | 53.33 | 1.023 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Crispr Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 47.93 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Crispr Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 47.93 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.